CCM
ASTH icon

Cadence Capital Management’s Astrana Health ASTH Stock Holding History

Cadence Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-79,475
Closed -$1.58M – 464
2018
Q4 		$1.58M Buy
79,475
+6,121
+8% +$115K 0.16% 196
2018
Q3 		$1.62M Buy
+73,354
New +$1.54M 0.09% 315

Other funds holding ASTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MF
Manchester Financial Westlake Village, California $563M AUM 21.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cadence Capital Management's ASTH Position: Q1 2019 in Review

Cadence Capital Management sold out of Astrana Health (ASTH) in Q1 2019, closing a stake of 79,475 shares — an estimated $1.58M sold.

Cadence Capital Management first reported a position in ASTH in Q3 2018 and held it in 2 quarters. The position peaked at $1.62M in Q3 2018. 37 funds tracked by Wall St. Rank hold ASTH as of Q1 2019.

  • Cadence Capital Management reported no remaining Astrana Health position as of Q1 2019 after selling out during the quarter.
  • Cadence Capital Management sold 79,475 Astrana Health shares in Q1 2019, an estimated $1.58M.
  • Cadence Capital Management first reported a position in Astrana Health in Q3 2018 and held it in 2 quarters.
  • Cadence Capital Management's Astrana Health position peaked at $1.62M in Q3 2018.
  • 37 funds tracked by Wall St. Rank held Astrana Health as of Q1 2019.

Based on Cadence Capital Management's 13F filing for Q1 2019, filed 7 May 2019.